Cabazitaxel or mitoxantrone with prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: Final results of a multinational phase III trial (TROPIC)
Tarih
2010Yazar
Matthews, P.
Sartor, A. O.
De Bono, J. S.
Oudard, S.
Ozguroglu, M.
Hansen, S.
Machiels, J. H.
Shen, L.
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Makale [92796]
